Whether successful treatment of depression reduces the risk for progression needs to be determined.
Sotagliflozin might help patients with diabetes and chronic kidney disease who are hospitalized with heart failure avoid a readmission, study results suggest.
A low-cost, group-delivered lifestyle intervention is associated with a significantly lower risk for progression to type 2 diabetes among high-risk individuals.
Investigators sought to determine whether younger age at diagnosis, female sex, and higher weight z score and HbA1c are risk factors for C-peptide decline after new onset of pediatric type 1 diabetes.
The study goal was to determine whether real-time continuous glucose monitoring up to 24 months is beneficial, particularly in persons living with impaired awareness of hypoglycemia.
The BLA is supported by data from a phase 2 trial that evaluated whether teplizumab could prevent or delay the onset of T1D in at-risk individuals.
Finerenone vs placebo added to standard therapy was associated with a significant 18% reduction in the risk for major adverse kidney events in patients with both chronic kidney disease and type 2 diabetes mellitus.
Clinical use of FRAX without bone mineral density can be used to identify adults with type 1 diabetes who are at elevated risk for major osteoporotic fracture.
The effects of the COVID-19 pandemic on the diagnosis and presentation of pediatric type 1 diabetes.
Children who received a new diagnosis of type 1 diabetes during the COVID-19 pandemic are presenting with higher rates of diabetic ketoacidosis than in the previous 2 years.
Vitamin D supplements may significantly improve neuropathic symptoms, including pain and quality of life.
Individuals with diabetes have an increased risk for hip and nonvertebral fractures.
Xeris Pharmaceuticals announced the launch of Gvoke HypoPen™ (glucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 2 years and older.
A clinical perspective article details the recommended approach to manage diabetic ketoacidosis in patients with diabetes during the COVID-19 pandemic.
Continuous glucose monitoring is a safe and useful method to measure blood glucose levels in the hospital, especially during the COVID-19 pandemic.
The association of pemphigus with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) is assessed.
Presentation patterns are similar in patients with type 1 diabetes admitted with confirmed or suspected COVID-19.
Acute hyperglycemia affects brain metabolite concentration and performance on spatial working memory tasks in adolescents with type 1 diabetes.
The FDA has approved Lyumjev™ (insulin lispro-aabc injection; Lilly) to improve glycemic control in adults with type 1 and type 2 diabetes.
The FDA has approved Semglee™ (insulin glargine injection; Mylan and Biocon) to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.